OTCMKTS:MMNFF MedMen Enterprises (MMNFF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsSEC Filings About MedMen Enterprises Stock (OTCMKTS:MMNFF) 30 days 90 days 365 days Advanced Chart Ad Wall Street StarHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the Get MedMen Enterprises alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume119,996 shsAverage Volume705,413 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. The company provides products under the MedMen Red and LuxLyte brand names. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts. MedMen Enterprises Inc. is based in Los Angeles, California.Read More… Receive MMNFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedMen Enterprises and its competitors with MarketBeat's FREE daily newsletter. Email Address MMNFF Stock News HeadlinesCannabis Company MedMen Goes Bankrupt With $411 Million In LiabilitiesApril 29, 2024 | forbes.comCannabis firm MedMen enters bankruptcy proceedings in Canada, receivership in USApril 29, 2024 | proactiveinvestors.comWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.December 18, 2024 | Behind the Markets (Ad)Cannabis company MedMen files for bankruptcy with about $411M in liabilities as its fortunes go up in smokeApril 29, 2024 | msn.comMedMen Announces Entering Bankruptcy Proceedings and Resignation of CFO and DirectorsApril 26, 2024 | businesswire.comMedMen Appoints Expert Richard Ormond as Chief Restructuring OfficerJanuary 25, 2024 | msn.comMedMen Enterprises Announces Regulation FD DisclosureJanuary 25, 2024 | msn.comMedMen goes from height of $3B valuation to zero as stock draws cease-trade orderJanuary 24, 2024 | msn.comSee More Headlines MMNFF Stock Analysis - Frequently Asked Questions How were MedMen Enterprises' earnings last quarter? MedMen Enterprises Inc. (OTCMKTS:MMNFF) announced its earnings results on Monday, February, 15th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.03. Read the conference call transcript. How do I buy shares of MedMen Enterprises? Shares of MMNFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings2/15/2021Today12/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers—Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:MMNFF CUSIPN/A CIK1776932 Webwww.medmen.com Phone(855) 292-8399FaxN/AEmployees428Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:MMNFF) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedMen Enterprises Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MedMen Enterprises With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
